FDA Grants Breakthrough Designation for Axial Spondyloarthritis Diagnostic Test
The multiplex immunoassay measures autoantibodies to the 14-3-3eta protein and aims to reduce diagnostic delays that currently average seven to 10 years.
Latest Articles
Editor's Top Picks
Lab Sets Guinness World Record for DNA Sequencing Speed
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
Be the First to Know What’s Next in the Lab
Every week, we dig into the biggest shifts, breakthroughs, and tech transforming clinical diagnostics. Straightforward, insightful, and always relevant.Critical Resources
Diagnostic Innovations
10x Genomics Launches Next Generation of Chromium Flex to Scale Single-Cell Research
New plate-based multiplexing can profile up to 384 samples and 100 million cells per week.
Equipment & Supply Spotlight
Azenta Life Sciences Launches New Cap Carrier Formats to Expand Sample Management Options
The 24- and 48-format carriers join the existing 96-format solution to provide laboratories with scalable tube processing workflows.
News, Know-How & Standards
Disease Detection & Understanding
Blood Test Shows Promise for Tailoring Colon Cancer Chemotherapy
Circulating tumor DNA testing can identify stage 3 patients who may safely receive reduced treatment intensity, international study finds.
